Paul Burridge

Publications

• A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. Mordwinkin NM, Burridge PW, Wu JC. J Cardiovasc Transl Res. 2013; 6 (1): 22-30
• Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. Thompson SA, Burridge PW, Lipke EA, Shamblott M, Zambidis ET, Tung L. J Mol Cell Cardiol. 2012; 53 (1): 15-23
• Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Gu E, Chen WY, Gu J, Burridge P, Wu JC. Theranostics. 2012; 2 (4): 335-45
• Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Burridge PW, Keller G, Gold JD, Wu JC. Cell Stem Cell. 2012; 10 (1): 16-28
• A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. PLoS One. 2011; 6 (4): e18293
• Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Gundry RL, Burridge PW, Boheler KR. Proteomics. 2011; 11 (20): 3947-61